Survival statistics for immunohistochemical markers in primary and... | Download Table
Cancers | Free Full-Text | Targeted Gene Delivery Therapies for Cervical Cancer
DRH1 – a novel blood-based HPV tumour marker - eBioMedicine
First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research
Cervical cancer stem cell‑associated genes: Prognostic implications in cervical cancer (Review)
Molecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high-grade cervical disease | BioTechniques
Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies - ScienceDirect
Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC
Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives: Molecular Therapy - Oncolytics
Ovarian tumor markers: What to draw and when | MDedge ObGyn
IJMS | Free Full-Text | Low P16INK4A Expression Associated with High Expression of Cancer Stem Cell Markers Predicts Poor Prognosis in Cervical Cancer after Radiotherapy
Cancers | Free Full-Text | Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity - eBioMedicine
Tumor Marker Score for Prognostication of Early-stage Squamous Cell Cervical Cancer | Anticancer Research
Currently available and potentially useful serum markers for cervical... | Download Table
Bevacizumab in the Treatment of Cervical Cancer – Current Evidence and Next Steps - touchONCOLOGY
Guidelines for the Use of Tumor Markers in Cervical Cancer | Semantic Scholar
Noninvasive Point-of-Care Nanobiosensing of Cervical Cancer as an Auxiliary to Pap-Smear Test | ACS Applied Bio Materials
Tumor Marker Score for Prognostication of Early-stage Squamous Cell Cervical Cancer | Anticancer Research
Table I from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar
Frontiers | Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry
